Harris, Emily and Bova, Kaitlin (2019) Patient engagement throughout drug development: understanding the role of patients and best practices for engagement. SOCRA Source, 101. pp. 28-31.

Abstract

Although greater than 70% of the population believes patients should actively be involved in drug development, patient engagement is currently not a standard practice for the pharmaceutical industry.1 Patients are experts in their disease states, and the pharmaceutical industry can utilize their expertise to improve drug development. Patient engagement can be used in the development process to develop patient-focused protocols, improve recruitment, and gain a better understanding of what it is like to live with a disease. This paper aims to explore recommendations for involving patients in the drug development process, and to discuss the benefits and barriers of patient engagement.

Item Type:	Article
Date Deposited:	29 Oct 2019 00:45
Last Modified:	29 Oct 2019 00:45
URI:	https://oak.novartis.com/id/eprint/39187